Clinic growth opportunity
The UK's most in-demand injectable — and the margin to match
Dermal fillers are now the single biggest revenue driver in UK aesthetic clinics, accounting for a significant share of the £500 million market. Neauvia PEG-HA fillers give your clinic access to next-generation technology that delivers longer-lasting, natural results with fewer complications — exactly what today's more informed patients are looking for. If you're not yet offering fillers, or want to upgrade what you're currently using, this is where to start.
Proven patient demand
Over 52% of UK filler patients are under 35, and the market is adding a new demographic every year — from millennial preventative patients to a rapidly growing male audience.
Strong, repeat revenue
Fillers require maintenance every 6 to 18 months, depending on the area, making every new patient a reliable returning one, not a one-off booking.
Superior technology
Neauvia's PEG crosslinking offers improved stability, reduced post-treatment swelling, and a more natural result compared to standard HA fillers — giving your clinic a credible point of difference.
CE-marked, medically regulated product
Full-face range: lips, cheeks, jawline, chin, skin quality
Reversible HA formula — patient confidence built in